EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy

Gamze Sanlav, Selen Kum Ozsengezer, Zekiye Altun iD, Erdal Bedir, Safiye Aktas, Nur Olgun

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgaf131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Gamze Sanlav und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Oncology, Dokuz Eylul University, Izmir 35330, Turkey. Hauptthemen laut MEDLINE: Cisplatin, Neuroblastoma, Apoptosis, Autophagy. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Institutes of Turkey, Dokuz Eylul University Department of Scientific Research Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Neuroblastoma (NB), the most common extracranial tumor in childhood, has a poor prognosis, especially in cases with MYC gene amplification. Cisplatin (CDDP) is widely used in treatment, but its effectiveness is limited due to chemotherapy resistance. Autophagy plays a dual role in cancer progression, either promoting survival or contributing to cell death.

Methods

This study explores the anticancer effects of K41-A, a polycyclic polyether molecule, alone and in combination with CDDP in SH-SY5Y and KELLY NB cell lines, the HE-IOC1 noncancerous cochlear cell line, and the NB xenograft model. Key findings For the first time, we demonstrate that K41-A, either alone or combined with CDDP, significantly inhibits cell proliferation selectively in NB cells, sparing noncancerous cells. This study confirmed that K41-A alone and in combination with CDDP induced changes in both apoptotic and autophagic cell death components in NB, resulting in antiproliferative activity in vitro and in vivo. In addition, the combination with CDDP enhanced the therapeutic efficacy of K41-A.

Conclusions

These results highlight the potential of K41-A as a candidate drug for the treatment of NB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinNeuroblastomaApoptosisAutophagyCell ProliferationAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsHumansAnimalsCell Line, TumorMiceXenograft Model Antitumor AssaysDrug SynergismMice, Nude

Stichwörter der Autor:innen

K41-Aapoptosisautophagyneuroblastomapolyether

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Basic Oncology, Dokuz Eylul University, Izmir 35330, Turkey.
  • Department of Bioenginering, Izmir Institute of Technology, Izmir 35430, Turkey.
  • Department of Pediatric Oncology, Dokuz Eylul University, Izmir 35330, Turkey.

ORCID-Profile: Zekiye Altun

Förderung

  • Health Institutes of Turkey
  • Dokuz Eylul University Department of Scientific Research Projects

Zitieren

APA

Sanlav, G., Kum Ozsengezer, S., Altun, Z., Bedir, E., Aktas, S., & Olgun, N. (2026). K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf131

Vancouver

Sanlav G, Kum Ozsengezer S, Altun Z, Bedir E, Aktas S, Olgun N. K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgaf131

BibTeX
@article{Sanlav2026,
  author = {Sanlav, Gamze and Kum Ozsengezer, Selen and Altun, Zekiye and Bedir, Erdal and Aktas, Safiye and Olgun, Nur},
  title = {K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgaf131}
}
Kostenlos starten →